XORTX Therapeutics Inc (XRTX)
1.32
+0.02
(+1.54%)
USD |
NASDAQ |
Nov 14, 16:00
1.35
+0.03
(+2.27%)
After-Hours: 20:00
XORTX Therapeutics Enterprise Value: 0.6962M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.6962M |
| November 12, 2024 | 0.6962M |
| November 11, 2024 | 0.9866M |
| November 08, 2024 | 1.393M |
| November 07, 2024 | 1.118M |
| November 06, 2024 | 1.132M |
| November 05, 2024 | 0.9866M |
| November 04, 2024 | 0.8414M |
| November 01, 2024 | 1.074M |
| October 31, 2024 | 1.073M |
| October 30, 2024 | 1.219M |
| October 29, 2024 | 1.335M |
| October 28, 2024 | 1.437M |
| October 25, 2024 | 1.422M |
| October 24, 2024 | 1.277M |
| October 23, 2024 | 1.509M |
| October 22, 2024 | 1.422M |
| October 21, 2024 | 1.887M |
| October 18, 2024 | 2.380M |
| October 17, 2024 | 2.206M |
| October 16, 2024 | 3.222M |
| October 15, 2024 | 2.351M |
| October 14, 2024 | 1.335M |
| October 11, 2024 | 1.364M |
| October 10, 2024 | 1.451M |
| Date | Value |
|---|---|
| October 09, 2024 | 1.858M |
| October 08, 2024 | 2.148M |
| October 07, 2024 | 1.364M |
| October 04, 2024 | 1.393M |
| October 03, 2024 | 1.364M |
| October 02, 2024 | 1.399M |
| October 01, 2024 | 1.422M |
| September 30, 2024 | 1.683M |
| September 27, 2024 | 1.422M |
| September 26, 2024 | 1.335M |
| September 25, 2024 | 1.887M |
| September 24, 2024 | 1.683M |
| September 23, 2024 | 1.683M |
| September 20, 2024 | 2.003M |
| September 19, 2024 | 2.032M |
| September 18, 2024 | 1.945M |
| September 17, 2024 | 2.003M |
| September 16, 2024 | 2.322M |
| September 13, 2024 | 2.061M |
| September 12, 2024 | 1.858M |
| September 11, 2024 | 2.061M |
| September 10, 2024 | 2.700M |
| September 09, 2024 | 2.787M |
| September 06, 2024 | 2.729M |
| September 05, 2024 | 4.006M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.337M
Minimum
Mar 28 2023
63.05M
Maximum
Sep 07 2021
8.663M
Average
6.410M
Median
Nov 09 2020
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 836.78M |
| Edesa Biotech Inc | 5.103M |
| Lexaria Bioscience Corp | 26.69M |
| Xenon Pharmaceuticals Inc | 2.455B |
| ESSA Pharma Inc | -51.27M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.1701M |
| Total Expenses (Quarterly) | 1.494M |
| EPS Diluted (Quarterly) | 0.06 |
| Earnings Yield | -37.13% |